GRANULOMATOSIS WITH POLYANGIITIS
Clinical trials for GRANULOMATOSIS WITH POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new GRANULOMATOSIS WITH POLYANGIITIS trials appear
Sign up with your email to follow new studies for GRANULOMATOSIS WITH POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a dengue vaccine protect those with autoimmune conditions?
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a live attenuated dengue vaccine (Butantan-DV) in people aged 12–59 with autoimmune rheumatic diseases like rheumatoid arthritis or lupus, who are stable and on low or no immune-suppressing drugs. Researchers want to see if the vaccine is safe and triggers a…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:16 UTC
-
Could less steroid be safer for vasculitis patients?
Disease control Recruiting nowThis study tests whether a shorter, lower-dose steroid treatment (4 weeks) combined with standard medications works as well as the usual longer steroid course for people with ANCA vasculitis and severe kidney disease. About 36 adults with a new or returning flare of this conditio…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated May 26, 2026 04:10 UTC
-
Promising antibody therapy aims to calm rare autoimmune disease flare-ups
Disease control Recruiting nowThis study tests a drug called obinutuzumab in 33 adults with a relapsing form of a rare autoimmune disease that inflames blood vessels (PR3-ANCA granulomatosis with polyangiitis). The goal is to see if the drug can stop disease activity and normalize blood markers within 6 month…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
New hope for rare disease patients: study tests three rescue treatments for stubborn vasculitis
Disease control Recruiting nowThis study is for people with granulomatosis with polyangiitis, a rare disease where blood vessels get inflamed, who haven't improved with usual treatments. It compares three different drug combinations to see which works best to control the disease. About 42 adults will take par…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 20, 2026 11:56 UTC